Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT05699005 Recruiting - Anemia Clinical Trials

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

ICONE
Start date: September 18, 2023
Phase: Phase 1
Study type: Interventional

This multicenter randomized controlled trial compare two transfusion strategies of red blood cells transfusion in patients supported by veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock. An individualized transfusion strategy based on ScVO2 level, is compared to a conventionnal strategy based on predefined hemoglobin threshold. The primary endpoint is the consumption of packed red blod cells, secondary endpoints are subgroup analysis, mortality, morbidity, and cost-effectiveness

NCT ID: NCT05697770 Recruiting - Shock Clinical Trials

SODium BICarbonate for Metabolic Acidosis in the ICU

SODa-BIC
Start date: April 26, 2023
Phase: Phase 3
Study type: Interventional

This trial aims to assess if, among adults in the ICU with metabolic acidosis, an infusion of sodium bicarbonate diluted in 5% dextrose, compared with an infusion of 5% dextrose, reduces Major Adverse Kidney Events within 30 days of randomization.

NCT ID: NCT05681052 Recruiting - Septic Shock Clinical Trials

Mottling Score and Central Venous Oxygen Saturation in Septic Shock Patients

Start date: October 1, 2022
Phase:
Study type: Observational

Mottling score and central venous oxygen saturation are described as a clinical evaluation of tissue perfusion. This study describes mottling incidence and mottling score in septic shock patients according to central venous oxygen saturation.

NCT ID: NCT05664399 Recruiting - Clinical trials for Physiologic Responses to Surprise Events

Shock Factor: Effects of Surprise on Cardiovascular Responses.

Start date: November 24, 2022
Phase:
Study type: Observational

This research will determine the breathing, heart rate and other responses to four surprise events. For two events, virtual reality goggles will be used to create a realistic experience of falling out of a boat and rolling out of a boat or falling of a paddleboard. Two final events will involve falling into a dunk tank with either cool (20℃) or cold (10℃) water.

NCT ID: NCT05630716 Recruiting - Sepsis Clinical Trials

Non-Invasive Cardiac Output Monitor (NICOM) for Goal-directed Fluid Resuscitation for Inpatients With Hypotension and/or Septic Shock

Start date: July 31, 2023
Phase: N/A
Study type: Interventional

The Non-Invasive Cardiac Output Monitor (NICOM) is a non-invasive monitor capable of measuring cardiac output (CO) and cardiac index (CI), and stroke volume (SV) and stroke volume index (SVI) based on heart rate. Conceptually NICOM is a technology that utilizes a dynamic response characteristic in assessing the need for fluid administration, whereby SVI is measured before and after a fluid challenge with more fluid given only if SVI increases significantly with administered fluid. Dynamic response technologies are intended to replace older, "static" measures such as central venous pressure (CVP) and pulmonary capillary wedge pressures (PCWP) which are single point measurements utilized to assess the need to administer fluid. The aim is to pilot and evaluate the effectiveness of using The Non-Invasive Cardiac Output Monitor (NICOM) technology for goal-directed fluid resuscitation in adult inpatients with sepsis associated acute hypotension and/or evidence of septic shock (Lactate >= 4.0).

NCT ID: NCT05613647 Recruiting - Shock Clinical Trials

Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring

PICC-ECHO
Start date: December 13, 2022
Phase:
Study type: Observational [Patient Registry]

Shock is a serious complication corresponding to acute circulatory failure resulting in multiorgan failure and death. In order to improve cellular oxygen utilization, several therapies can be used. To select one of them, the monitoring of cardiac output is helpful. However, there are several methods used in current practice in intensive care for evaluating hemodynamic. Currently, in patients with acute circulatory failure, no study has compared the concordance of therapeutic decision-making based on transpulmonary thermodilution or transthoracic echocardiography. The objective of the PICC-ECHO study is thus to assess the concordance of therapeutic decision-making by several experts, based on data from transpulmonary thermodilution or transthoracic echocardiography. Indeed, the investigators hypothesize that performing hemodynamic monitoring based on transpulmonary thermodilution or transthoracic echocardiography does not lead to the same therapeutic management in patients in shock.

NCT ID: NCT05594342 Recruiting - Heart Failure Clinical Trials

Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support

IVA-CS
Start date: July 1, 2022
Phase: Phase 3
Study type: Interventional

Data regarding the safety and efficacy of ivabradine use in severely decompensated HFrEF requiring inotropic support is limited to case series.1 This study aimed to evaluate ivabradine safety and tolerability in admitted cardiogenic shock patients who started on dobutamine infusion for inotropic support.

NCT ID: NCT05577195 Recruiting - Cardiogenic Shock Clinical Trials

Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

Prospective, multi-center, randomized (1:1), controlled trial of Impella for active left ventricular unloading on top of veno-arterial extracorporeal membrane oxygenation vs. veno-arterial extracorporeal membrane oxygenation alone for the treatment of cardiogenic shock.

NCT ID: NCT05575856 Recruiting - Cardiogenic Shock Clinical Trials

Cardiogenic Shock Registry Mannheim

CARESMA
Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

The study aims to investigate clinically and prognostically relevant parameters in patients with cardiogenic shock within a monocentric observational clinical register.

NCT ID: NCT05557461 Recruiting - Sepsis Clinical Trials

Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?

Start date: September 20, 2022
Phase:
Study type: Observational

Fluid therapy is important in patients with sepsis and septic shock. There are many invasive and non-invasive methods to assess fluid responsiveness in patients. The specificities and sensitivities of these methods are highly variable. The reason for our study was to determine end-tidal co2 and fluid responsiveness in septic shock patients. The aim of the study was to evaluate the fluid response using the End-tidal CO2 difference in septic shock patients receiving intubated mechanical ventilation support.